603707.SHG Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
8.59 CNY
Close of Nov 4, 2026
6.72 10.46
Market cap
CNY 13.9B
P/E
33.0x
P/B
1.89x
ROE
5.2%
Dividend yield
1.57%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603707.SHG undervalued?

Graham number
Price8.59
Graham value5.16
Premium66.6%

603707.SHG trades 66.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanjing King-friend Biochemical Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Nanjing King-friend Biochemical Pharmaceutical Co Ltd yet.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceutical raw materials and preparations in China and internationally. The company offers generics for oncology, critical care, IVF, and diabetes; and standard heparin preparations and low molecular weight heparin preparations, including enoxaparin sodium injections, dalteparin sodium injection, and nadroparin calcium injection. It also provides non-hepa…

Full company profile